Advanced search
Publication Cover
Cancer Investigation Volume 26, 2008 - Issue 8
Submit an article Journal homepage
600
Views
77
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECellular and Molecular Biology

TLR4 Signaling Induces B7-H1 Expression Through MAPK Pathways in Bladder Cancer Cells

Yigang Qian Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Junfang Deng Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Lei Geng Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Haiyang Xie Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Guoping Jiang Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Lin Zhou Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Yan Wang Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Shenyong Yin Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Xiaowen Feng Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Junwei Liu Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Zhou Ye Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
&
Shusen Zheng Department of Hepatobiliary Pancreatic Surgery, Key Lab of Organ Transplantation of Zhejiang Province, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
 show all
Pages 816-821 | Published online: 11 Jun 2009

Citations (77)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jing-Jing Wang, Michelle K. Siu, Yu-Xin Jiang, Thomas H. Leung, David W. Chan, Ran-Ran Cheng, Annie N. Cheung, Hextan Y. Ngan & Karen K. Chan. (2019) Aberrant upregulation of PDK1 in ovarian cancer cells impairs CD8+ T cell function and survival through elevation of PD-L1. OncoImmunology 8:11.
Read now

Articles from other publishers (76)

Ying Deng, Vojtech Adam, Eugenie Nepovimova, Zbynek Heger, Marian Valko, Qinghua Wu, Wei Wei & Kamil Kuca. (2023) c-Jun N-terminal kinase signaling in cellular senescence. Archives of Toxicology 97:8, pages 2089-2109.
Crossref
Yiping Lu, Miao Yu, Jinsheng Ye, Yankai Liang, Jianxin Gao, Zhen Ji & Jie Wang. (2023) Sauchinone Inhibits the Proliferation and Immune Invasion Capacity of Colorectal Cancer Cells through the Suppression of PD-L1 and MMP2/MM9. Anti-Cancer Agents in Medicinal Chemistry 23:12, pages 1406-1414.
Crossref
Vandana Anang, Aayushi Singh, Sarat Kumar Kottarath & Chaitenya Verma. 2023. Receptor Endocytosis and Signalling in Health and Disease - Part A. Receptor Endocytosis and Signalling in Health and Disease - Part A 219 267 .
Piero Giuseppe Meliante, Christian Barbato, Federica Zoccali, Massimo Ralli, Antonio Greco, Marco de Vincentiis, Andrea Colizza, Carla Petrella, Giampiero Ferraguti, Antonio Minni & Marco Fiore. (2022) Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies. International Journal of Molecular Sciences 23:23, pages 15384.
Crossref
Carlos Wagner S. Wanderley, Alexandre G.M. Maganin, Beatriz Adjafre, Atlante S. Mendes, Conceição Elidianne Anibal Silva, Andreza Urba Quadros, João Paulo Mesquita Luiz, Camila Meirelles S. Silva, Nicole R. Silva, Francisco Fabio Bezerra Oliveira, Francisco Isaac F. Gomes, Jeferson Leandro J. Restrepo, Cesar A. Speck-Hernandez, Fernanda Turaça, Gabriel Victor Lucena Silva, Glauce R. Pigatto, Helder I. Nakaya, Jose Mauricio Mota, Romualdo Barroso-Sousa, José C. Alves-Filho, Thiago M. Cunha & Fernando Q. Cunha. (2022) PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling. Cancer Immunology Research 10:11, pages 1299-1308.
Crossref
Xiaofan Duan, Xiaoxiao Xu, Yumei Zhang, Yuan Gao, Jiuli Zhou & Jin Li. (2022) DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor‐infiltrating T cells through IL ‐18 . Cancer Science 113:11, pages 3672-3685.
Crossref
Thomas Denize, Yue Hou, Jean-Christophe Pignon, Emily Walton, Destiny J. West, Gordon J. Freeman, David A. Braun, Catherine J. Wu, Saurabh Gupta, Robert J. Motzer, Michael B. Atkins, David McDermott, Toni K. Choueiri, Sachet A. Shukla & Sabina Signoretti. (2022) Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma. Clinical Cancer Research 28:18, pages 4045-4055.
Crossref
Yanmeizhi Wu, Shan Yu & Hong Qiao. (2022) Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer. Frontiers in Pharmacology 13.
Crossref
Hirohito Yamaguchi, Jung-Mao Hsu, Wen-Hao Yang & Mien-Chie Hung. (2022) Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nature Reviews Clinical Oncology 19:5, pages 287-305.
Crossref
Maria A. Papadaki, Alexia Monastirioti, Christina A. Apostolopoulou, Despoina Aggouraki, Chara Papadaki, Kleita Michaelidou, Maria Vassilakopoulou, Katerina Alexakou, Dimitrios Mavroudis & Sofia Agelaki. (2022) TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications. Cancers 14:4, pages 1053.
Crossref
Sareshma Sudhesh Dev, Syafiq Asnawi Zainal Abidin, Reyhaneh Farghadani, Iekhsan Othman & Rakesh Naidu. (2021) Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer. Frontiers in Pharmacology 12.
Crossref
Yaolin Xu, Lijie He, Qiang Fu & Junzhe Hu. (2021) Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints. Frontiers in Oncology 11.
Crossref
Karen Bräutigam, Elodie Kabore-Wolff, Ahmad Fawzi Hussain, Stephan Polack, Achim Rody, Lars Hanker & Frank Köster. (2021) Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines. Journal of Cancer Research and Clinical Oncology 147:10, pages 2923-2933.
Crossref
Ronan W. Hsieh, Steven Borson, Anastasia Tsagianni & Dan P. Zandberg. (2021) Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck. Frontiers in Oncology 11.
Crossref
Jihyun Moon, Yoo Min Oh & Sang-Jun Ha. (2021) Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications. BMB Reports 54:8, pages 403-412.
Crossref
Lijuan Gao & Yongshun Chen. (2021) Autophagy controls programmed death‑ligand 1 expression on cancer cells (Review). Biomedical Reports 15:4.
Crossref
Hao Zhang, Ziyu Dai, Wantao Wu, Zeyu Wang, Nan Zhang, Liyang Zhang, Wen-Jing Zeng, Zhixiong Liu & Quan Cheng. (2021) Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Ying Chen, Fangxuan Li, Dan Li, Wenxin Liu & Lei Zhang. (2021) Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway. Clinical Immunology 227, pages 108728.
Crossref
Shing Yau Tam & Helen Ka-Wai Law. (2021) JNK in Tumor Microenvironment: Present Findings and Challenges in Clinical Translation. Cancers 13:9, pages 2196.
Crossref
Jun-Chieh J. Tsay, Benjamin G. Wu, Imran Sulaiman, Katherine Gershner, Rosemary Schluger, Yonghua Li, Ting-An Yie, Peter Meyn, Evan Olsen, Luisannay Perez, Brendan Franca, Joseph Carpenito, Tadasu Iizumi, Mariam El-Ashmawy, Michelle Badri, James T. Morton, Nan Shen, Linchen He, Gaetane Michaud, Samaan Rafeq, Jamie L. Bessich, Robert L. Smith, Harald Sauthoff, Kevin Felner, Ray Pillai, Anastasia-Maria Zavitsanou, Sergei B. Koralov, Valeria Mezzano, Cynthia A. Loomis, Andre L. Moreira, William Moore, Aristotelis Tsirigos, Adriana Heguy, William N. Rom, Daniel H. Sterman, Harvey I. Pass, Jose C. Clemente, Huilin Li, Richard Bonneau, Kwok-Kin Wong, Thales Papagiannakopoulos & Leopoldo N. Segal. (2021) Lower Airway Dysbiosis Affects Lung Cancer Progression. Cancer Discovery 11:2, pages 293-307.
Crossref
Mariana Segovia-Mendoza, Susana Romero-Garcia, Cristina Lemini & Heriberto Prado-Garcia. (2021) Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation. Journal of Immunology Research 2021, pages 1-18.
Crossref
Liangliang Cai, Jianchun Duan, Li Qian, Zhijie Wang, Shuhang Wang, Sini Li, Chao Wang, Jie Zhao, Xue Zhang, Hua Bai & Jie Wang. (2020) ROS1 Fusion Mediates Immunogenicity by Upregulation of PD-L1 After the Activation of ROS1–SHP2 Signaling Pathway in Non-Small Cell Lung Cancer. Frontiers in Immunology 11.
Crossref
Jiaming He, Wenkan Zhang, Tuoyu Di, Jiahong Meng, Yiying Qi, Guoqi Li, Yuxiang Zhang, Hang Su & Weiqi Yan. (2020) Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody. Biomedicine & Pharmacotherapy 131, pages 110541.
Crossref
Jonas Eichberger, Daniela Schulz, Kristian Pscheidl, Mathias Fiedler, Torsten Eugen Reichert, Richard Josef Bauer & Tobias Ettl. (2020) PD-L1 Influences Cell Spreading, Migration and Invasion in Head and Neck Cancer Cells. International Journal of Molecular Sciences 21:21, pages 8089.
Crossref
Parisa Lotfinejad, Tohid Kazemi, Ahad Mokhtarzadeh, Dariush Shanehbandi, Farhad Jadidi Niaragh, Sahar Safaei, Milad Asadi & Behzad Baradaran. (2020) PD-1/PD-L1 axis importance and tumor microenvironment immune cells. Life Sciences 259, pages 118297.
Crossref
Yoshimitsu Kiriyama, Anna Tani, Minako Kadoya, Ryoko Okamoto & Hiromi Nochi. (2020) Induction of PD-L1 by Nitric Oxide <i>via</i> JNK Activation in A172 Glioblastoma Cells. Biological and Pharmaceutical Bulletin 43:6, pages 1020-1022.
Crossref
Annika C. Betzler, Marie-Nicole Theodoraki, Patrick J. Schuler, Johannes Döscher, Simon Laban, Thomas K. Hoffmann & Cornelia Brunner. (2020) NF-κB and Its Role in Checkpoint Control. International Journal of Molecular Sciences 21:11, pages 3949.
Crossref
Xiuhua Kang, Penghui Li, Chuibin Zhang, Yunshan Zhao, Huoli Hu & Guilan Wen. (2020) The TLR4/ERK/PD‑L1 axis may contribute to NSCLC initiation. International Journal of Oncology 57:2, pages 456-465.
Crossref
Luoyan Ai, Antao Xu & Jie Xu. 2020. Regulation of Cancer Immune Checkpoints. Regulation of Cancer Immune Checkpoints 33 59 .
Li Yang, Aitian Li, Qingyang Lei & Yi Zhang. (2019) Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. Journal of Hematology & Oncology 12:1.
Crossref
Solmaz Ohadian Moghadam & Mohammad Reza Nowroozi. (2019) Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy. Scandinavian Journal of Immunology 90:6.
Crossref
Xiangfeng Shen, Lihong Zhang, Jicheng Li, Yulin Li, Yishu Wang & Zhi-Xiang Xu. (2019) Recent Findings in the Regulation of Programmed Death Ligand 1 Expression. Frontiers in Immunology 10.
Crossref
Pawel Kalinski & Per Basse. 2019. Immune Checkpoint Inhibitors in Cancer. Immune Checkpoint Inhibitors in Cancer 1 17 .
Yongyu Shi. (2018) Regulatory mechanisms of PD-L1 expression in cancer cells. Cancer Immunology, Immunotherapy 67:10, pages 1481-1489.
Crossref
Alexandr V. Bazhin, Katharina von Ahn, Jasmin Fritz, Jens Werner & Svetlana Karakhanova. (2018) Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling. Frontiers in Immunology 9.
Crossref
Ioannis Zerdes, Alexios Matikas, Jonas Bergh, George Z. Rassidakis & Theodoros Foukakis. (2018) Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations. Oncogene 37:34, pages 4639-4661.
Crossref
Chong Sun, Riccardo Mezzadra & Ton N. Schumacher. (2018) Regulation and Function of the PD-L1 Checkpoint. Immunity 48:3, pages 434-452.
Crossref
Juan Sun, Meng Lian, Hongzhi Ma, Ru Wang, Zhihong Ma, Haizhou Wang, Jie Zhai, Lingzhao Meng, Ling Feng, Yunfei Bai, Xiaobo Cui & Jugao Fang. (2017) Competing endogenous RNA network analysis of CD274, IL‑10 and FOXP3 co‑expression in laryngeal squamous cell carcinoma. Molecular Medicine Reports.
Crossref
Sabine Groeger, Fabian Jarzina, Eugen Domann & Joerg Meyle. (2017) Porphyromonas gingivalis activates NFκB and MAPK pathways in human oral epithelial cells. BMC Immunology 18:1.
Crossref
S. R. Kumar, D. Y. Kim, C. J. Henry, J. N. Bryan, K. L. Robinson & A. M. Eaton. (2017) Programmed death ligand 1 is expressed in canine B cell lymphoma and downregulated by MEK inhibitors. Veterinary and Comparative Oncology 15:4, pages 1527-1536.
Crossref
Seda Sabah-Ozcan, Aykut Baser, Taha Olcucu, Ikbal Cansu Barıs, Levent Elmas, Levent Tuncay, Saadettin Eskicorapci, Nilay Sen Turk & Vildan Caner. (2017) Human TLR gene family members are differentially expressed in patients with urothelial carcinoma of the bladder. Urologic Oncology: Seminars and Original Investigations 35:12, pages 674.e11-674.e17.
Crossref
Elizabeth D Thompson, Janis M Taube, Rebecca J Asch-Kendrick, Aleksandra Ogurtsova, Haiying Xu, Rajni Sharma, Alan Meeker, Pedram Argani, Leisha A Emens & Ashley Cimino-Mathews. (2017) PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breast. Modern Pathology 30:11, pages 1551-1560.
Crossref
Kyoung-Jin Kim, Ji-Hye Kim, Seo Jin Lee, Eun-Jung Lee, Eui-Cheol Shin & Jinsil Seong. (2017) Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model. Oncotarget 8:25, pages 41242-41255.
Crossref
Satoshi Tsutsumi, Hiroshi Saeki, Yuichiro Nakashima, Shuhei Ito, Eiji Oki, Masaru Morita, Yoshinao Oda, Shinji Okano & Yoshihiko Maehara. (2017) Programmed death‐ligand 1 expression at tumor invasive front is associated with epithelial‐mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma. Cancer Science 108:6, pages 1119-1127.
Crossref
Steven C. Kao, Yuen Yee Cheng, Marissa Williams, Michaela B. Kirschner, Jason Madore, Trina Lum, Kadir H. Sarun, Anthony Linton, Brian McCaughan, Sonja Klebe, Nico van Zandwijk, Richard A. Scolyer, Michael J. Boyer, Wendy A. Cooper & Glen Reid. (2017) Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology.
Crossref
Jing Zhang, Ya-qin Tan, Ming-hui Wei, Xiao-jing Ye, Guan-ying Chen, Rui Lu, Ge-fei Du & Gang Zhou. (2017) TLR4-induced B7-H1 on keratinocytes negatively regulates CD4 + T cells and CD8 + T cells responses in oral lichen planus . Experimental Dermatology 26:5, pages 409-415.
Crossref
S. Kang, C. Zhang, T. Ohno & M. Azuma. (2017) Unique B7-H1 expression on masticatory mucosae in the oral cavity and trans-coinhibition by B7-H1-expressing keratinocytes regulating CD4+ T cell-mediated mucosal tissue inflammation. Mucosal Immunology 10:3, pages 650-660.
Crossref
Kaiyuan Wang, Jian Wang, Feng Wei, Ning Zhao, Fan Yang & Xiubao Ren. (2017) Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy. Frontiers in Immunology 8.
Crossref
Tsutomu Tanaka, Goro Kutomi, Toshimitsu Kajiwara, Kazuharu Kukita, Vitaly Kochin, Takayuki Kanaseki, Tomohide Tsukahara, Yoshihiko Hirohashi, Toshihiko Torigoe, Yoshiharu Okamoto, Koichi Hirata, Noriyuki Sato & Yasuaki Tamura. (2017) Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer. Oncotarget 8:15, pages 24706-24718.
Crossref
Kenneth Oguejiofor, Henry Galletta-Williams, Simon J. Dovedi, Darren L. Roberts, Peter L. Stern & Catharine M.L. West. (2017) Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic. Oncotarget 8:9, pages 14416-14427.
Crossref
Yukiyoshi Hirayama, Min Gi, Shotaro Yamano, Hirokazu Tachibana, Takahiro Okuno, Satoshi Tamada, Tatsuya Nakatani & Hideki Wanibuchi. (2016) Anti‐PD‐L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma. Cancer Science 107:12, pages 1736-1744.
Crossref
Emily A. Lanzel, M. Paula Gomez Hernandez, Amber M. Bates, Christopher N. Treinen, Emily E. Starman, Carol L. Fischer, Deepak Parashar, Janet M. Guthmiller, Georgia K. Johnson, Taher Abbasi, Shireen Vali & Kim A. Brogden. (2016) Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models. Cancer Immunology, Immunotherapy 65:12, pages 1511-1522.
Crossref
Amin Afsharimoghaddam, Mohammad Soleimani, Alireza Lashay, Mahdi Dehghani & Zahra Sepehri. (2016) Controversial roles played by toll like receptor 4 in urinary bladder cancer; A systematic review. Life Sciences 158, pages 31-36.
Crossref
Naoki Takahashi, Satoru Iwasa, Yusuke Sasaki, Hirokazu Shoji, Yoshitaka Honma, Atsuo Takashima, Natsuko Tsuda Okita, Ken Kato, Tetsuya Hamaguchi & Yasuhide Yamada. (2016) Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer. Journal of Cancer Research and Clinical Oncology 142:8, pages 1727-1738.
Crossref
Melanie Ruf, Holger Moch & Peter Schraml. (2016) PD‐L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma. International Journal of Cancer 139:2, pages 396-403.
Crossref
Antonio D Bardoli, Mehran Afshar, Richard Viney, Mike Foster, Emilio Porfiri, Anjali Zarkar, Robert Stevenson, Nicholas D James, Richard T Bryan & Prashant Patel. (2016) The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic target. Future Oncology 12:5, pages 595-600.
Crossref
Hyangsoon Noh, Jiemiao Hu, Xiaohong Wang, Xueqing Xia, Arun Satelli & Shulin Li. (2015) Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells. Cell Communication and Signaling 13:1.
Crossref
Dingzhi Wang & Raymond N. DuBois. (2015) Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis 36:10, pages 1085-1093.
Crossref
Patcharee Ritprajak & Miyuki Azuma. (2015) Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma. Oral Oncology 51:3, pages 221-228.
Crossref
Sanjay PandeySaurabh SinghVandana AnangAnant N. BhattK. NatarajanBilikere S. Dwarakanath. (2015) Pattern Recognition Receptors in Cancer Progression and Metastasis. Cancer Growth and Metastasis 8, pages CGM.S24314.
Crossref
Alexandr V. Bazhin, Katharina von Ahn, Caroline Maier, Sabine Soltek, Susanne Serba, Linda Diehl, Jens Werner & Svetlana Karakhanova. (2014) Immunological in vivo effects of B7-H1 deficiency. Immunology Letters 162:2, pages 273-286.
Crossref
Yaíma L. Lightfoot, Tao Yang, Bikash Sahay, Mojgan Zadeh, Sam X. Cheng, Gary P. Wang, Jennifer L. Owen & Mansour Mohamadzadeh. (2014) Colonic Immune Suppression, Barrier Dysfunction, and Dysbiosis by Gastrointestinal Bacillus anthracis Infection. PLoS ONE 9:6, pages e100532.
Crossref
Pei-Min Li, Yu-Liang Li, Bin Liu, Wu-Jie Wang, Yong-Zheng Wang & Zheng Li. (2014) Curcumin Inhibits MHCC97H Liver Cancer Cells by Activating ROS/TLR-4/Caspase Signaling Pathway. Asian Pacific Journal of Cancer Prevention 15:5, pages 2329-2334.
Crossref
Yong-Hua Wang, Yan-Wei Cao, Xue-Cheng Yang, Hai-Tao Niu, Li-Jiang Sun, Xin-Sheng Wang & Jing Liu. (2014) Effect of TLR4 and B7-H1 on Immune Escape of Urothelial Bladder Cancer and its Clinical Significance. Asian Pacific Journal of Cancer Prevention 15:3, pages 1321-1326.
Crossref
Ivraym B. Barsoum, Chelsea A. Smallwood, D. Robert Siemens & Charles H. Graham. (2014) A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells. Cancer Research 74:3, pages 665-674.
Crossref
Huang Ying, Liu Da, Shi Yu-xiu, Xia Yu, Liu Li-xia, Xie Li-mei & Ren Wei-dong. (2013) TLR4 Mediates MAPK–STAT3 Axis Activation in Bladder Epithelial Cells. Inflammation 36:5, pages 1064-1074.
Crossref
Hélène LaRue, Cherifa Ayari, Alain Bergeron & Yves Fradet. (2013) Toll-like receptors in urothelial cells—targets for cancer immunotherapy. Nature Reviews Urology 10:9, pages 537-545.
Crossref
Chuanbiao Ji, Yonghua Wang, Qinchao Yu, Jing Liu, Yanan Liu & Jie Cui. (2013) Expression and significance of B7-H1 in peripheral blood dendritic cells from patients with bladder cancer. The Chinese-German Journal of Clinical Oncology 12:6, pages 290-292.
Crossref
Gang Huang, Qianjun Wen, Yongliang Zhao, Qiangguo Gao & Yun Bai. (2013) NF-κB Plays a Key Role in Inducing CD274 Expression in Human Monocytes after Lipopolysaccharide Treatment. PLoS ONE 8:4, pages e61602.
Crossref
Xiaofeng Jiang, Jun Zhou, Anita Giobbie-Hurder, Jennifer Wargo & F. Stephen Hodi. (2013) The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition. Clinical Cancer Research 19:3, pages 598-609.
Crossref
Sabine Groeger, Eugen Domann, Jose R. Gonzales, Trinad Chakraborty & Joerg Meyle. (2011) B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology 216:12, pages 1302-1310.
Crossref
Yujia Cao, Lu Zhang, Pacharee Ritprajak, Fumihiko Tsushima, Pornpan Youngnak-Piboonratanakit, Yosuke Kamimura, Masaaki Hashiguchi & Miyuki Azuma. (2011) Immunoregulatory Molecule B7-H1 (CD274) Contributes to Skin Carcinogenesis. Cancer Research 71:14, pages 4737-4741.
Crossref
Cherifa Ayari, Alain Bergeron, Hélène LaRue, Claire Ménard & Yves Fradet. (2011) Toll-Like Receptors in Normal and Malignant Human Bladders. The Journal of Urology 185:5, pages 1915-1921.
Crossref
Yael S. Barach, Jun Sik Lee & Xingxing Zang. (2011) T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics. Trends in Molecular Medicine 17:1, pages 47-55.
Crossref
Céline Berthon, Virginie Driss, Jizhong Liu, Klaudia Kuranda, Xavier Leleu, Nathalie Jouy, Dominique Hetuin & Bruno Quesnel. (2010) In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunology, Immunotherapy 59:12, pages 1839-1849.
Crossref
S. Roperto, N.A. Colabufo, C. Inglese, C. Urraro, R. Brun, E. Mezza, S. Staibano, C. Raso, P. Maiolino, V. Russo, E. Palma & F. Roperto. (2010) Sigma-2 Receptor Expression in Bovine Papillomavirus-Associated Urinary Bladder Tumours. Journal of Comparative Pathology 142:1, pages 19-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.